Advancements without consensus: differing practice patterns highlight unanswered questions in the management of brain metastases from EGFR- and ALK-positive non-small cell lung cancer

J Thorac Dis. 2023 Nov 30;15(11):5877-5884. doi: 10.21037/jtd-23-1483. Epub 2023 Oct 28.
No abstract available

Keywords: Non-small cell lung cancer (NSCLC); anaplastic lymphoma kinase (ALK); brain metastases; epidermal growth factor receptor (EGFR); practice patterns.

Publication types

  • Editorial
  • Comment